x

Search for a clinical trial

* (*) mandatory field

An Open-Label Study for Previously Treated Ataluren (PTC124) Patients With Nonsense Mutation Dystrophinopathy (Phase III) - IT

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Terminated trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Ptc therapeutics, inc.
    • Phase : III
  • Principal investigator of clinical trial

  • Pr Enrico S. BERTINI
  • UnitÓ di Malattie Neuromuscolari e Neurodegenerative - Laboratorio di Medicina Molecolare
  • Dipartimento di Neuroscienze e Neuroriabilitazione
  • IRCCS Ospedale Pediatrico Bambino Ges¨ - SEDE SAN PAOLO
  • Viale di San Paolo 15
  • 00146 ROMA RM
  • ITALY
  • More information
  • Phone  : 39 06 68592105
  • Fax  : 39 06 68592024
  • Website
Last update: May 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.